Scarica l'app Stockscreener
92.36
3.21%
-3.06
Dopo l'orario di chiusura:
92.01
-0.35
-0.38%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PTGX Giù?
Forum
Previsione
Protagonist Therapeutics Inc Azioni (PTGX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
57.83%
7.437
|
4.712 | 5.546 | 28.32 | 4.675 |
Operating Expenses
|
13.02%
57.79
|
51.13 | 47.59 | 47.63 | 46.13 |
| Benefits Costs and Expenses |
16.13%
51.16
|
44.05 | 40.15 | 39.98 | 38.30 |
| Costs And Expenses |
16.13%
51.16
|
44.05 | 40.15 | 39.98 | 38.30 |
| Operating Income/Loss |
8.47%
-50.35
|
-46.42 | -42.04 | -19.31 | -41.45 |
| Income/Loss From Continuing Operations Before Tax |
11.13%
-43.72
|
-39.34 | -34.60 | -11.65 | -33.63 |
| Income Tax Expense/Benefit |
0.666
|
- | 0.172 | - | -0.42 |
| Income/Loss From Continuing Operations After Tax |
12.82%
-44.38
|
-39.34 | -34.77 | -11.65 | -33.21 |
|
Net Income/Loss
|
12.82%
-44.38
|
-39.34 | -34.77 | -11.65 | -33.21 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
99.76%
0.1545
|
63.77 | 63.51 | 62.96 | 61.77 |
| Diluted Average Shares |
99.76%
0.1545
|
63.77 | 63.51 | 62.96 | 61.77 |
| Basic Earnings Per Share |
12.90%
-0.70
|
-0.62 | -0.55 | -0.19 | -0.54 |
| Diluted Earnings Per Share |
12.90%
-0.70
|
-0.62 | -0.55 | -0.19 | -0.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):